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OsteocyteThe role of gap junctions, particularly that of connexin43 (Cx43), has become an area of increasing
interest in bone physiology. An abundance of studies have shown that Cx43 inﬂuences the function
of osteoblasts and osteocytes, which ultimately impacts bone mass acquisition and skeletal homeo-
stasis. However, the molecular details underlying how Cx43 regulates bone are only coming into
focus and have proven to be more complex than originally thought. In this review, we focus on
the diverse molecular mechanisms by which Cx43 gap junctions and hemichannels regulate cell sig-
naling pathways, gene expression, mechanotransduction and cell survival in bone cells. This review
will highlight key signaling factors that have been identiﬁed as downstream effectors of Cx43 and
the impact of these pathways on distinct osteoblast and osteocyte functions.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The normal development and maintenance of skeletal tissue is
dependent on the tightly coordinated activity of osteoblasts,
osteoclasts, and osteocytes. Osteoblasts form new bone, osteoclasts
resorb bone and osteocytes seem to coordinate the activation of
these two cell types. In order for the bone embedded osteocytes
(Fig. 1A and C) to direct bone formation and resorption on bone
surfaces, there is an obvious need for these cells to signal over a
substantial distance, impeded by the presence of a mineralized
matrix (Fig. 1A and B). This is accomplished both by the release
of soluble signals (e.g., RANKL, osteoprotegerin and sclerostin)
and by direct cell-to-cell communication through gap junctions.
Indeed, osteocytes have an extensive network of long, dendritic-
like cell processes that extend through the canaliculi of bone,
where they physically interconnect with adjacent osteocytes
and with osteogenic cells on the bone surface via connexin43
(Cx43)-containing gap junctions (Fig. 1B and C). Likewise, surface
osteoblasts, osteoprogenitors and bone lining cells express Cx43
and form functional gap junctions among each other as with
osteocytes. The result is a functional syncytium of interconnectedcells throughout bone that acts in concert to orchestrate the forma-
tion and turnover of bone.
A number of compelling studies over the past decade have dem-
onstrated that gap junctions play an integral role in coordinating
the activities of these different cell types in bone. Speciﬁcally,
Cx43 can regulate osteoblast differentiation, bone formation and
bone resorption. Mechanistic details are emerging as to how gap
junctional intercellular communication (GJIC) impacts the cellular
processes that affect skeletal homeostasis. Understanding how
Cx43 affects these processes is critically important as there are di-
verse mechanisms by which Cx43 can carry out its function in
these cells, each with distinct consequences, some that enhance
bone quality (osteo-anabolic) and others that are detrimental (os-
teo-catabolic). This review revisits some of the key ﬁndings high-
lighting the important role of gap junctions in bone and will
emphasize the emerging details and recent contributions towards
elucidating the molecular mechanisms by which Cx43 gap junc-
tions regulate signal transduction pathways, gene expression,
mechanotransduction and cell survival in bone cells.
2. Gap junctions and skeletal function
Gap junctions, which are made up of connexin protein mono-
mers, are specialized intercellular membrane channels that func-
tion as aqueous conduits between the cytoplasm of contiguous
Fig. 1. Interconnected network of osteoblasts and osteocytes. (A) Osteocytes (arrows) are embedded in bone and yet they direct the activity of osteoprogenitor (asterisks)
cells on the bone surface. (B) Immunoﬂuorescence of Cx43 (green) shows expression at the osteocyte cell body (arrows), as well as throughout the canalicular network
extending through the mineralized cortical bone. Cx43 is also abundantly expressed by osteoblasts on the bone surface (asterisks). (C) Illustration of osteocytes embedded in
bone. Long dendritic-like processes, enable contact between osteocytes and surface osteoblasts. Cx43 containing gap junctions form between the osteocytes and osteoblasts,
(a) which allows the exchange of molecules between the cells. Osteocytes are also known to express Cx43 hemichannels (b), that allow for the release of factors into the
extracellular space. The regulation of bone resorption by osteoclasts is mediated by osteoblast/osteocyte produced RankL and OPG. The balance of these factors in the control
of osteoclast formation is a target of Cx43.
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small molecules and second messengers between neighboring
cells. Furthermore, gap junction channels do not function in isola-
tion, but rather, aggregate into gap junction plaques that can con-
tain thousands of channels and range from <100 nm to several
micrometers in diameter [1]. Accordingly, GJIC can provide the
means for a dynamic, interconnected network of cells. In addition
to classic GJIC, unopposed gap junction hemichannels exist at the
membrane, where they function as direct conduits between the
cytosol and extracellular milieu [2,3].
The most abundantly expressed gap junction protein in bone is
Cx43, encoded by the Gja1 gene. Gap junction channels comprised
of Cx43 typically permit the passage of molecules less than
1.2 kDa in size, whereas larger molecules, proteins and nucleic
acids are generally restricted from passage. Cells of the osteoblast
lineage also express other connexins, including Cx45, Cx40, Cx46
and Cx37, however the contributions of these gap junction proteins
to skeletal homeostasis are still unclear.
3. Cx43, osteoblast differentiation, and skeletal development
Several lines of evidence underscore the importance of Cx43 in
bone. First, mutation of GJA1 results in oculodentodigital dysplasia
(ODDD), a pleiotropic hereditary disease characterized by craniofa-
cial, neurologic, limb and ocular abnormalities [4,5]. Mouse models
of ODDD have shown that these mutations frequently lead todominant negative action of Cx43 and results in changes to bone
geometry, bone microarchitecture and osteopenia [6,7]. In addi-
tion, mutation of GJA1 can lead to craniometaphyseal dysplasia
with skeletal phenotypes distinct from ODDD [8]. Second, genetic
ablation of Gja1 either globally or in conditional knockout models
within the osteoblast lineage consistently results in a skeletal phe-
notype, including delayed osteoblast differentiation, osteopenia,
and changes in skeletal geometry that are remindful of those ob-
served in patients with ODDD, including broadening of the circum-
ference of long bones with an expansion of the marrow cavity and
often with thinned cortex [9–14]. The expansion of the cross sec-
tional area and change in geometry of the long bones in ODDD
and/or Gja1 genetic ablation in bone are strikingly similar to the
skeletal phenotype of aging and disuse [12]. Third, Cx43 has been
shown to be an important modulator of the ability of bone and
bone cells to respond to mechanical cues, hormonal and growth
factor stimulation and to facilitate bone healing following fracture
[10,11,15,16]. These topics of the in vivo effects of Cx43 are re-
viewed in greater detail elsewhere [17,18]. We will focus on the
molecular underpinnings for the remainder of this review.
The involvement of Cx43 in the processes that control bone cell
function and ultimately bone quality is conspicuously complex,
with differential responses based on the context of the effect. For
example, loss of Cx43 differentially modulates the response of
bone cells on the periosteal and endosteal surface of bone in
response to mechanical loading [11]. Somewhat paradoxically, loss
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blunts the effects of mechanical unloading or perhaps even aging
induced bone loss [19,20]. This implies that Cx43 transmits signals
that can be either osteo-anabolic or osteo-catabolic, depending on
the context such as aging, mechanical loading or unloading, or
even location (i.e., differential effects on the periosteal and endos-
teal surfaces of bone) [21]. This complexity underscores the need
to understand the speciﬁc details of how Cx43 affects bone cells
and bone remodeling and raises several important questions. What
are the second messengers and effectors of the osteo-anabolic
effects of Cx43 on bone? How do these differ from the effectors
of the osteo-catabolic actions? Can we selectively regulate the
ability to communicate and/or respond to some signals passed
through gap junctions but not others? Understanding the molecu-
lar mechanisms by which Cx43 can modulate bone cell function in
a context dependent manner is critical to the development of
treatments that modulate these connexin-regulated pathways to
enhance or maintain bone quality.
4. Molecular mechanisms of Cx43 signal transduction in bone
One of the most common models for how Cx43 function affects
cell function is related to classic GJIC. In this model, the passage of
second messengers among cells by gap junctions converges on sig-
naling pathways downstream of the gap junction [22]. Speciﬁcally,
a target cell can respond to stimuli by producing second messen-
gers that further participate in downstream signaling pathways
to elicit effects on gene transcription and cell function. In addition
to evoking a response in the targeted cell, these second messengers
can also pass through gap junctions and elicit the same response in
neighboring recipient cells. The ability to communicate or share
these second messengers results in a concerted and ampliﬁed acti-
vation of signaling cascades among a population of cells. Indeed,
work from our laboratory has used this model to explain how
increasing GJIC can enhance signal transduction cascades and gene
expression in bone cells [17]. According to this model, if cells share
second messenger signals via gap junctions, then a greater number
of cells can respond to the cue that initiated the signaling event.
Conversely, loss of Cx43 would limit osteo-anabolic signal ex-
change via GJIC resulting in delays in osteoblast differentiation
and function and leading to the skeletal phenotypes observed in
mouse models (reviewed in [21]). Similarly, in the context of a
bone catabolic environment such as hind limb unloading, disuse
or aging [11,20,23,24], Cx43 deletion may halt the communication
and prevent the ampliﬁcation of catabolic cues, reducing bone
destruction and preserving bone quality.
Admittedly, such a model lacks critical mechanistic details re-
lated to how Cx43 impacts bone cell function. For example, what
are the biologically relevant second messengers that are passing
through Cx43 gap junctions? Do connexins function simply in
the formation of a passive channel for signal diffusion, or do they
actively participate in signaling cascades that control osteoblast
differentiation and function? Further, to what extent do connexins
function in non-junctional roles such as hemichannels to modulate
cellular function? And what are the effectors mediating the effects
of Cx43 on bone homeostasis? Which of these effectors and second
messenger signals are osteo-anabolic? Which are osteo-catabolic?
To date, the most progress has been with regard to potential osteo-
anabolic signaling cascades that are enhanced by Cx43 expression.5. Cx43 and osteo-anabolic signaling pathways
One way that Cx43 regulates bone is through the control of
osteoblast differentiation and bone cell activity, as well as through
the expression of factors (e.g., RANKL and osteoprotegerin)controlling bone resorption by osteoclasts (Fig. 1C). Cell autono-
mous defects in cells of the osteoblast lineage underlie at least a
subset of the reduced bone quality caused by Cx43 gene deletion.
It seems there is an intrinsic inability of osteoblasts to optimally
express the genes necessary for matrix production, mineralization,
the suppression of bone resorption (osteoprotegerin) and progres-
sion through the osteogenic lineage in the absence of Cx43 [9,10].
This highlights that in certain contexts Cx43 is decidedly osteo-
anabolic. In vitro, alterations in Cx43 expression or function
modulate the expression of several osteoblast genes [25–30]. With
respect to how Cx43 regulates gene expression, osteoblast differ-
entiation and function, the effectors and signaling pathways are
complex. It is clear that there is no single effector of Cx43’s action
on bone cells.
One set of mechanisms responsible for Cx43-mediated regula-
tion of osteoblast differentiation and gene expression involves
the transcription factors Runx2 and Osterix (Sp7), both of which
are master regulators of osteogenesis. Cx43 overexpression or
knockdown modulates the transcriptional activity of both Runx2
and Osterix in MC3T3-E1 cells, thereby providing a potential
means by which Cx43 can impact the wide spectrum of osteoblast
gene transcription and osteoblast differentiation [31–34]. Two of
the downstream effectors of Cx43-activated signaling responsible
for modulating Runx2 and Osterix activity have been identiﬁed
(Fig. 2). In the case of Runx2, Cx43 affects the activation of extra-
cellular signal-regulated kinase (ERK) and protein kinase C delta
(PKCd), both of which work in parallel to enhance Runx2 activity
[28,29,33]. ERK and PKCd phosphorylate Runx2, increasing its tran-
scriptional activity [35–38]. Interestingly, ERK and PKCd physically
complex with Cx43, suggesting a point of spatial signaling control
[34,39,40]. Consistent with the action of Cx43 in this context as a
classic gap junction rather than via hemichannel activity, disrup-
tion of GJIC by pharmacological inhibition or culturing of cells in
low density abrogates the Cx43-dependent effects on Runx2
activity [33].
Similarly, Cx43-dependent modulation of ERK regulates the
recruitment of Osterix (as part of an Sp1-containing complex) to
osteoblast promoters [31,32]. Cx43 regulation of Sp1 has similarly
been reported in other cell types as well [41]. Taken together, these
ﬁndings demonstrate that Cx43 regulates the ERK and PKCd signal-
ing pathways, converging on the activity of osteogenic effector
molecules Runx2 and Osterix with clear effects on osteoblast gene
expression, which explains, at least in part, the osteo-anabolic
effects of Cx43 on bone.
An important question is, what is the identity of the secondmes-
senger signals being shared by bone cells via Cx43 to carry out these
effects on transcription? Recent work has identiﬁed inositol
polyphosphates as biologically relevant second messengers that
may be a key signal communicated by Cx43 among bone cells that
impacts Runx2 activation by activating PKCd [42]. In Cx43-
overexpressing MC3T3-E1 cells treated with FGF2, inhibition of
phospholipase C gamma1 (PLCc1), inositol phosphate multikinase
and inositol hexakisphosphate kinase 1 (IP6K1), which produce
inositol polyphosphate second messengers such as IP3, IP5, IP6 and
IP7, results in less PKCd phosphorylation, nuclear translocation
and interaction with Runx2 and consequently abrogates the
Cx43-dependent enhancement in Runx2 activity. Considering that
IP3 passes through Cx43 gap junctions [43], this provides evidence
into a potential second messenger upstream of Cx43 that is com-
municated through gap junctions and activates PKCd in adjacent
bone cells. Inositol polyphosphates are probably one of many
second messengers of biologic importance that are communicated
through Cx43 channels that positively or negatively affect bone cell
function.
There is evidence that the control of gene expression and
bone cell function by Cx43 is evolutionarily conserved. In zebraﬁsh,
Fig. 2. Overview of Cx43-associated signaling pathways. This schematic illustrates some of the identiﬁed signaling factors that are regulated downstream of Cx43 in
osteoblasts and osteocytes. (A) Cx43 impacts osteogenic gene expression via the activation of either ERK or PKCd, which have been shown to interact with Cx43. The
transmission of a signal via Cx43 gap junctions (Cx43 GJ) activates ERK or PKCd, which leads to the activation of osteogenic transcription factors Runx2 or Osterix in the
nucleus. In zebraﬁsh, Cx43 GJIC can also induce the expression of Semaphorin3d, which gets secreted and interacts with surface receptors Neuropilin 2a (Nrp2a) and Plexin a3
(PlxnA3) on other cells. This releases the inhibitory effect of Nrp2a and PlxnA3 on the expression of genes that regulate cell proliferation and joint formation respectively, thus
allowing Semaphorin3a to mediate the inductive effect of Cx43 on bony ﬁn formation in zebraﬁsh. (B) Mechanical force can trigger the opening of Cx43 hemichannels (Cx43
HC) by stimulating PI3K signaling. PI3K acts on integrin a5b1 and induces a conformational change that drives the opening of Cx43 HCs (red arrow) and the release of osteo-
anabolic factors such as prostaglandin E2 (PGE2) into the extracellular space. PGE2 can then bind to its cognate EP2 receptor, which stimulates b-catenin accumulation
through cAMP/PKA and PI3K/AKT signaling. b-Catenin can then induce the expression of osteogenic genes. (C) Cx43 HCs can also mediate the anti-apoptotic effects of
bisphosphonates and parathyroid hormone (PTH) on osteocytes. In response to bisphosphonates, Cx43 HCs can trigger the activation of Src/ERK signaling, resulting in the
activation of anti-apoptotic proteins p90RSK and C/EBPb. Conversely, during PTH signaling, Cx43 HCs can associate with barrestin, thus preventing it from inhibiting the action
of the parathyroid hormone 1 receptor and allows for the continued propagation of cell survival signals. Crosstalk also exists where the integrin a5b1 conformational change
in response to mechanical force can also stimulate focal adhesion kinase (FAK) and Src signaling and promote cell survival, and b-catenin can also regulate genes responsible
for cell survival.
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ing Cx43 affects the length of skeletally-derived ﬁn segments
resulting in distinct short ﬁn and long ﬁn phenotypes, respectively
[44,45]. Cx43 expression in the regenerating ﬁn rays of zebraﬁsh
affects the expression of a key secreted factor, semaphorin3d
[46] (Fig. 2). Semaphorin3d can then signal through two other
factors, neuropilin2a and plexin a3, which in turn regulates
proliferation and joint formation by skeletal precursor cells that
ultimately control bone tissue morphogenesis and ﬁn growth
[46]. Accompanying these ﬁndings is the intriguing observation
that the upregulation of semaphorin3d does not occur in the
proliferating Cx43-positive blastema cells responsible for bony
ﬁn growth, but rather in a non-proximal tissue compartment of
the ﬁn ray containing lateral skeletal precursor cells, emphasizing
the importance of the cell-to-cell signaling and coordinated multi-
cellular function in this model [47]. As such, semaphorin3d is a
critical downstream effector of Cx43-controlled bony ﬁn growth.
Cumulatively, these identiﬁed molecular mechanisms provide
compelling evidence as to how Cx43 affects signal transduction
cascades, such as ERK and PKCd, in order to regulate downstream
osteogenic processes such as gene transcription. Further, thesestudies provide insights as to why this ‘‘information sharing’’ of
second messengers carries great consequence towards osteoblast
function and bone physiology. In brief, it seems that Cx43 not only
participates in the gap junctional transmission of second messen-
gers between cells, but Cx43 also reinforces the signaling pathways
activated by these second messengers in adjacent cells, thereby
increasing the activation of these signaling pathways downstream
of the gap junction channel. Many other mediators (both second
messengers and signal pathways) that affect gene expression
may exist downstream of Cx43 in bone cells, and identiﬁcation of
these mediators is important in developing a complete picture of
the signaling factors that contribute to the role of Cx43 in bone.6. Cx43 signaling during mechanotransduction
A second means by which Cx43 affects bone is via its role in
transducing mechanical load signals among bone cells. An impor-
tant cue that regulates the anabolic and catabolic action of bone
cells on the skeleton is mechanical stress. Bone is amazingly adept
at modulating the skeletal microarchitecture to adapt to changing
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fect of Cx43 gene deletion on the mechano-responsiveness of bone
have revealed the importance of Cx43 in translating both osteo-
anabolic and osteo-catabolic mechanical responses from osteo-
cytes into the remodeling of bone [11,19,20,23,48]. In vitro, osteo-
blasts and osteocytes can respond to mechanical perturbation and/
or ﬂuid ﬂow-induced mechanical stress by producing calcium
oscillations that can propagate among cells in a Cx43-dependent
manner [49–51]. These Cx43-dependent calcium oscillations be-
tween osteocytes and osteoblasts can be reproduced ex vivo in in-
tact bone in response to mechanical stress on the cells [52,53].
Thus, calcium or effectors of calcium signaling, such as IP3, may
be second messengers used by bone cells to transduce mechanical
load signals though gap junctions. It is not yet known if these path-
ways then converge upon the ERK or PKCd pathways to regulate
osteoblast gene expression via Runx2 or Osterix or if they take
their own unique path to modulate bone cell function.
In addition to classic cell-to-cell communication through gap
junction channels, several studies suggest that Cx43 hemichannels
contribute to mechanical signaling in osteocytes. In response to
ﬂuid ﬂow-induced mechanical stress, MLO-Y4 osteocyte-like cells
release prostaglandin E2 (PGE2) via opening of Cx43 hemichannels
[54,55] (Fig. 2). The opening of hemichannels occurs as a result of a
physical interaction between Cx43 hemichannels and a5b1 inte-
grins [56]. In this context, ﬂuid ﬂow-induced mechanical stress re-
sults in the PI3K-dependent phosphorylation of a5b1, inducing a
conformation change in the integrin, opening the Cx43 hemichan-
nel. Subsequently, PGE2 can be released through the Cx43 hemi-
channel. With regard to mechano-signaling in bone, PGE2 signals
through its cognate EP2 receptors, which induces the activation
of PI3K/AKT pathway and accumulation of cAMP [57,58]. Both
cAMP/PKA- and PI3K/AKT-dependent pathways converge on b-
catenin signaling, a key effector of mechanical load responses by
bone cells [59–62]. PGE2 also induces Cx43 expression and GJIC
in osteocytes and osteoblasts [58,63]. Thus, PGE2 may function
both as an osteoanabolic mediator of Cx43 hemichannel function,
while also enhancing GJIC, increasing the propagation of intercellu-
lar mediators of mechanical load among bone cells. It should be
noted that there are two levels of controversy with respect to
Cx43 hemichannel function in bone. First, the in vivo relevance
of Cx43 hemichannels is unclear, as characterization of mice
expressing an ODDD-causing Cx43 mutant, which has defective
GJIC but hyperactive hemichannel function, largely phenocopies
the Cx43 conditional knockout models with respect to bone
[7,12]. Second, bone cells isolated from Cx43-deﬁcient mice are
as effective as wild type bone cells at releasing PGE2 in response
to ﬂuid ﬂow [64]. In fact, in this study the authors convincingly
demonstrate pannexin1 activity rather than Cx43 hemichannel
activity was required for PGE2 release. Additional work, particu-
larly using in vivo models, is necessary to clarify the role of GJIC,
Cx43 hemichannels and pannexins in mechanotransduction in
bone. Regardless, it is clear that Cx43 plays a large role in how bone
homeostasis is controlled not only during osteo-anabolic activities,
such as mechanical stress induced by exercise, but also during os-
teo-catabolic activities, such as the removal of mechanical signals
as a result of exposure to microgravity or disuse. Little is known
about the nature of these osteo-catabolic signals that are propa-
gated through Cx43 to impact bone quality.
7. Cx43 mechanisms of osteocyte apoptosis and survival
A third means by which Cx43 impacts bone quality is through
regulation of osteocyte apoptosis. Osteocyte death is exacerbated
in various catabolic bone syndromes [65,66]. Increased apopto-
sis of osteocytes may compromise the mechanosensory andcommunicative function of bone cells, leading to increased bone
resorption and low bone mass [67,68]. Hence, there is great inter-
est in determining what regulates osteocyte death and the down-
stream consequences on bone remodeling.
In mouse models, conditional deletion of Cx43 from late stage
osteoblast and osteocytes results in increased osteocyte apoptosis
[14,20]. Perplexingly, no increase in osteocyte death is observed in
Cx43 conditional knockout mice with deletion of Cx43 in the entire
osteoblast lineage (rather than just late stage osteoblasts and
osteocytes) [12]. The reasons for this discrepancy are not clear,
as all of these models lack Cx43 in the osteocyte compartment,
but perhaps it implies that GJIC between osteoprogenitor cells
and osteocytes produces survival signals that are in direct opposi-
tion to those exchange by osteocytes and late osteoblasts.
Undoubtedly, clariﬁcation of this point is critical to understanding
all of the ways that Cx43 can regulate bone homeostasis.
Additionally, Cx43 can inﬂuence cell survival downstream of
speciﬁc cues. Cx43 is required for the anti-apoptotic action of bis-
phosphonates and parathyroid hormone (PTH) on osteocytes and
osteoblasts [69,70]. In the case of bisphosphonates, the opening
of Cx43 hemichannels by the indirect action of bisphosphonates
leads to the activation of ERK-dependent cell survival signals that
inactivate the pro-apoptotic effector BAD and drive the anti-apop-
totic actions of C/EBPb [69,71]. With respect to PTH, Cx43 can
mediate cell survival signals by forming a complex with b-arrestin,
effectively sequestering b-arrestin and permitting sustained action
of the parathyroid hormone 1 receptor (PTHR1) and the accumula-
tion of intracellular cAMP accumulation, leading to enhanced cell
survival [70]. The implication that cAMP is sufﬁcient to induce
osteocyte survival, even in the absence of Cx43, establishes that
cAMP may be another biologically relevant second messenger
transmitted by Cx43 gap junctions.
8. The Cx43 C-terminus and an active role for Cx43 in signaling
A particularly exciting role for Cx43 as an active participant in
signal transduction and not just a passive channel for second mes-
senger diffusion is emerging. The C-terminal (CT) domain of Cx43,
which is the least conserved of the connexin protein domains, has
been shown to bind to and/or be the target of numerous signaling
complexes [39,72]. While much of the focus of the gap junction
ﬁeld has been on how modulation of the connexin by these signal
complexes can regulate the open/closed state of gap junction chan-
nels (signaling to the gap junction), recent evidence demonstrates
a role for signaling from the Cx43 gap junction, as well.
Several in vitro structure-function studies show that the Cx43
C-terminus plays an important role in signaling and function of
bone cells. Overexpression of a full-length Cx43 construct, but
not a Cx43 mutant construct that lacks the C-terminus, enhances
the expression of osteoblast genes and supports the Cx43-depen-
dent potentiation of FGF2 signaling on Runx2 activity, despite both
constructs being able to support similar levels of GJIC [34]. Impor-
tantly, not only is the C-terminus required for the signaling and
transcriptional effects of Cx43 overexpression on bone cells, the
C-terminus is insufﬁcient to mimic the effects of Cx43 and is
antagonistic to signaling via the ERK and PKCd pathways and to
osteoblast gene expression. This requirement for the C-terminus
is consistent with the fact that PKCd complexes with Cx43 via its
C-terminus domain and upon activation translocates from Cx43
to the nucleus where it interacts with Runx2 [40,42]. This demon-
strates that both the communication function (Cx43 channel) and
the C-terminus of Cx43 are required for Cx43 to affect bone cells.
Likewise, a5 integrin-dependent opening of Cx43 hemichannels
following ﬂuid ﬂow requires the intact Cx43, while the Cx43 C-ter-
minus is antagonistic to hemichannel opening [56]. Also, a similar
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duced anti-apoptotic effect mediated by Cx43, although in this
context GJIC may not be required [70,71].
These experiments suggest that Cx43 serves, not only to ex-
change second messengers between cells, but also as a ‘‘docking
platform’’ for signaling complexes. In the three dimensional con-
text of the cell, location is important, and thus the ability to bring
signaling effector molecules (e.g., PKCd) to the unique cellular
microdomain (i.e., the membrane bound gap junction plaque)
where second messengers (e.g., IP7, cAMP) are exchanged is logical.
Therefore, intercellular communication and signal complex associ-
ation with the gap junction channel may be intertwined functions,
and the biologic activity of Cx43 may be determined, not only by
the charge and size selective permeability of gap junctions, but also
by the locally recruited signaling complexes associated with the
Cx43 C-terminus.
This model may explain, at least in part, the need for 20+ conn-
exin proteins, which often have overlapping permeability and yet
often serve unique biologic roles. Among connexins, the highly var-
iant C-terminus is primarily the site of signaling complexes inter-
actions. Extrapolating this model, it is possible that each
connexin may recruit its own unique subset of signaling com-
plexes, providing speciﬁc function to each connexin. While intrigu-
ing, these hypotheses still require rigorous testing, but they
highlight a novel role of Cx43 as an active regulator of signaling
and not just a passive channel for the intercellular diffusion of mol-
ecules that are small enough to pass through.9. Conclusion and future perspectives
In summary, Cx43 is crucial for skeletal homeostasis, regulating
bone cell function by actively participating in the regulation of sig-
naling, gene expression, cell survival and the ability to respond to
diverse cues, such as mechanical stress. The means by which Cx43
carries out these functions are numerous and are context speciﬁc,
communicating both osteo-anabolic and osteo-catabolic signals
within the skeletal network of cells. Indeed, even within the largely
anabolic signaling network, second messengers like inositol poly-
phosphates (e.g., IP3 and IP7), calcium and cAMP have all been
implicated (Fig. 2). These messengers converge on effectors includ-
ing PKCd, ERK, b-catenin, PI3K and PKA.
Despite signiﬁcant advances, much work remains to be done.
The links between the second messengers that are communicated
by Cx43 and cell function need to be deﬁned more clearly. The
nature of osteo-catabolic signals communicated by Cx43 needs to
be established. The identity of biologically relevant second
messengers must be determined. These studies will be critical for
understanding how Cx43 ultimately affects bone quality. This
knowledge may permit us to modulate Cx43-dependent processes
to increase bone cell function and bonemass accumulation in order
to prevent or treat diseases of skeletal fragility. Understanding the
coordination of osteoblast, osteocyte and osteoclasts networks is
vital to the understanding diseases of skeletal metabolism.
Interventions that can impact bone biology based on protein–
protein interactions and structure function analysis of Cx43 are
certainly feasible and have been successful in other tissues. For
example, the association of the Cx43 C-terminus to the tight
junction protein zonula occludens-1 (ZO-1) has been extensively
studied [39,73–76]. Recently, a mimetic peptide (alphaCT1) that
affects Cx43 C-terminus interactions with ZO-1 has been
demonstrated to be effective at improving corneal wound healing,
reducing scar tissue and improving healing time, and attenuating
injury-induced cardiac arrhythmia [76–78]. Accordingly, such
molecular dissections of Cx43 structure and function can have
important therapeutic potential.Acknowledgements
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